Those With Limited English Proficiency Face Barriers to Telehealth
By Lori Solomon HealthDay Reporter
THURSDAY, May 9, 2024 -- For individuals with limited English proficiency, there are disparities in telehealth access, as well as worse video visit experiences, according to a research letter published May 9 in JAMA Network Open.
Jorge A. Rodriguez, M.D., from Brigham and Women's Hospital in Boston, and colleagues used data from 24,453 adult participants in the 2021 California Health Interview Survey to examine differences in telehealth access and experiences between patients with limited English proficiency and patients with English proficiency.
The researchers found that patients with limited English proficiency were less likely to report either video or telephone telehealth use (37 versus 50 percent) compared with patients with English proficiency. Furthermore, patients with limited English proficiency reported worse experiences with video visits (32 versus 26 percent) compared with patients with English proficiency. There was no difference observed in visit experiences between the two groups for telephone visits (29 versus 31 percent).
"These findings highlight access to telephone visits alongside needed improvements to video visits for patients with limited English proficiency," the authors write. "Future work may evaluate the potential of digital navigators in improving the video visit experience."
One author disclosed ties to Valera Health, Clew, MDClone, FeelBetter, and AESOP Technology.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.